Lisdexamfetamine Dimesylate Capsule
Brand names: Lisdexamfetamine Dimesylate, Vyvanse
Category: Psychiatry
Unavailable 1Limited 32Available 56
FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Jan 11, 2024 (in shortage 2 years 8 months) · 13 manufacturers, 89 listed presentations
As of Sep 18, 2026, the FDA lists Lisdexamfetamine Dimesylate Capsule as currently in shortage. Of 89 manufacturer presentations, 1 Unavailable, 32 Limited, 56 Available.
Ask your pharmacist: which of the 13 manufacturers below can they order right now, and whether a different strength or form of Lisdexamfetamine Dimesylate Capsule is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) NDC 64850-550-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) NDC 0054-0660-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) NDC 43547-602-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) NDC 57664-046-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) NDC 47781-562-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) NDC 60505-4739-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) NDC 0527-4661-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) NDC 0378-6854-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) NDC 42858-161-01 |
Rhodes Pharmaceuticals L.P. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) NDC 0406-5111-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 10 mg (NDC 59417-101-10) NDC 59417-101-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) NDC 0480-3565-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) NDC 60505-4740-1 |
Apotex Corp. | Unavailable | Estimated recovery: 9/25/26 |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) NDC 64850-551-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) NDC 0054-0370-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) NDC 42858-162-01 |
Rhodes Pharmaceuticals L.P. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) NDC 43547-603-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) NDC 57664-047-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) NDC 47781-563-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) NDC 65162-023-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) NDC 0527-4662-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) NDC 0378-6855-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) NDC 0406-5112-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 20 mg (NDC 59417-102-10) NDC 59417-102-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) NDC 0480-3566-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) NDC 64850-552-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) NDC 0054-0371-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) NDC 42858-163-01 |
Rhodes Pharmaceuticals L.P. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) NDC 43547-604-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) NDC 47781-564-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) NDC 65162-024-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) NDC 60505-4741-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) NDC 0527-4663-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) NDC 0378-6856-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) NDC 0406-5113-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 30 mg (NDC 59417-103-10) NDC 59417-103-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) NDC 0480-3567-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) NDC 64850-553-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) NDC 0054-0372-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) NDC 42858-164-01 |
Rhodes Pharmaceuticals L.P. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) NDC 43547-605-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) NDC 57664-049-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) NDC 47781-565-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) NDC 65162-025-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) NDC 60505-4742-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) NDC 0527-4664-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) NDC 0378-6857-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) NDC 0406-5114-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 40 mg (NDC 59417-104-10) NDC 59417-104-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) NDC 0480-3568-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) NDC 64850-554-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) NDC 0054-0373-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) NDC 42858-165-01 |
Rhodes Pharmaceuticals L.P. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) NDC 43547-606-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) NDC 57664-050-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) NDC 47781-566-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) NDC 65162-026-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) NDC 60505-4743-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) NDC 0527-4665-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) NDC 0378-6858-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) NDC 0406-5115-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 50 mg (NDC 59417-105-10) NDC 59417-105-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) NDC 0480-3569-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) NDC 64850-555-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) NDC 0054-0374-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) NDC 43547-607-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) NDC 57664-051-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) NDC 47781-567-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) NDC 65162-027-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) NDC 60505-4744-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) NDC 0527-4666-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) NDC 0378-6859-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) NDC 42858-166-01 |
Rhodes Pharmaceuticals L.P. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) NDC 0406-5116-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 60 mg (NDC 59417-106-10) NDC 59417-106-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) NDC 0480-3570-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) NDC 64850-556-01 |
Elite Laboratories, Inc. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) NDC 0054-0375-25 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) NDC 42858-167-01 |
Rhodes Pharmaceuticals L.P. | Limited | Estimated recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) NDC 43547-608-10 |
Solco Healthcare US, LLC | Limited | On allocation |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) NDC 57664-052-88 |
Sun Pharmaceutical Industries, Inc. | Limited | Estimated Recovery: TBD |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) NDC 47781-568-01 |
Alvogen | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) NDC 65162-028-09 |
Amneal Pharmaceuticals | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) NDC 60505-4745-1 |
Apotex Corp. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) NDC 0527-4667-37 |
Lannett Company, Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) NDC 0378-6860-77 |
Mylan Pharmaceuticals Inc., a Viatris Company | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) NDC 0406-5117-01 |
SpecGx LLC | Available | - |
| Vyvanse, Capsule, 70 mg (NDC 59417-107-10) NDC 59417-107-10 |
Takeda Pharmaceuticals USA Inc. | Available | - |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) NDC 0480-3564-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
Related medications in shortage
Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Lisdexamfetamine Dimesylate Capsule (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Lisdexamfetamine Dimesylate Capsule. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Lisdexamfetamine Dimesylate Capsule.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/lisdexamfetamine-dimesylate-capsule.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).